Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efavirenz and CYP2B6 Polymorphism: Implications for Drug Toxicity and Resistance

4 Jan 2006

Abstract excerpt

The brief history of pharmacogenetics has been marked by a high level of public as well as professional interest, reflecting in many respects the great promise offered by genomic approaches to biology, clinical medicine, and pharmacology over the past ∼15 years. This early interest in personalized medicine was fueled by reviews [1, 2] in which it was predicted that drug prescribing could be undertaken with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to HIV/AIDS drug development and treatment
Share to Pharmacogenetics and Drug Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 16392090
DOI: 10.1086/499369

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efavirenz and CYP2B6 Polymorphism: Implications for Drug Toxicity and ResistancePMID 16392090Read ↗

Pharmacogenetics: data, concepts and tools to improve drug discovery and drug treatment.Semantic proximity Read ↗

Pharmacogenomics: Relevance and opportunities for clinical pharmacologySemantic proximity Read ↗

Pharmacogenetics and drug metabolism.Semantic proximity Read ↗

Pharmacogenetics and personalized medicine: the future for drug prescribing.Semantic proximity Read ↗

[How to individualize drug therapy based on pharmacogenetic information? A systematic review of published guidelines].Semantic proximity Read ↗

The Value of Clinical Pharmacogenomic Guidelines That Recommend Standard of Care Over Genotype-Based Prescribing.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: development, science, and translation.Semantic proximity Read ↗

Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future.Semantic proximity Read ↗

Advancing CYP2D6 Pharmacogenetics through a Pharmacoequity Lens.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Semantic proximity Read ↗

Impact of CYP polymorphisms, ethnicity and sex differences in metabolism on dosing strategies: the case of efavirenz.Semantic proximity Read ↗

CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations—Implication for Drug Safety, Dosing, and Individualized TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.